Gene Therapy Notes
Introduction
Gene therapy is an innovative medical approach that involves altering the genetic material within a person's cells to treat or prevent disease.
It is emerging as a powerful tool in the treatment of genetic disorders, certain types of cancer, and infectious diseases.
Gene therapy represents a significant shift in medicine, from managing symptoms to potentially curing diseases at their genetic root.
Role of Stem Cells in Gene Therapy
Stem cells play an important role in advancing gene therapy.
These undifferentiated cells have the unique ability to develop into various cell types, making them ideal carriers for introducing new or corrected genes into the body.
When combined, gene therapy and stem cell research offer transformative potential for regenerative medicine and personalized healthcare.
Discovering DNA
Scientists James Watson and Francis Crick discovered the structure of DNA in 1953.
Using X-ray crystallography techniques, they discovered that DNA is made of two strands coiled into a double helix shape.
Definition of Gene Therapy
Gene therapy is a medical approach that involves altering the genetic material inside a person's cells to treat or prevent disease.
It works by fixing defective genes or adding new, functional genes to help cells function properly.
The goal is to treat the underlying cause of a disease at the genetic level, rather than just managing symptoms (National Human Genome Research Institute, 2023).
How Gene Therapy Relates to Stem Cells
Stem cells as delivery vehicles:
Stem cells can be genetically modified outside the body and then transplanted back into the patient.
These cells can divide and produce healthy cells that carry the corrected gene.
Stem cells as gene therapy targets:
Gene therapy techniques can be applied directly to stem cells to correct their DNA.
These corrected stem cells can then multiply and give rise to healthy tissues.
This combination enhances long-term treatment effects since stem cells have the ability to self-renew and differentiate (Mayo Clinic, 2022; Genetics Home Reference, 2020).
Types of Genetic Modifications Used in Gene Therapy
Insertion:
Introducing a healthy gene into a specific site in the genome to replace a non-functioning or missing gene.
Removal (Gene Knockout):
Disabling a faulty gene that is causing a disease, for example, a gene that triggers abnormal cell growth.
Correction (Gene Editing):
Directly repairing mutations or abnormal sequences in DNA to restore normal gene function, often using tools like CRISPR-Cas9 (U.S. Food and Drug Administration, 2021; NIH, 2023).
Types and Methods of Gene Therapy
Core Classification of Gene Therapy Types
Germ Line Gene Therapy
Alters genes in reproductive cells (sperm or eggs).
Changes are heritable and passed to future generations.
Banned/prohibited in humans due to ethical and safety concerns.
Somatic Cell Gene Therapy
Alters genes in non-reproductive (body) cells.
Affects only the treated individual.
Widely used in current clinical research and therapy.
Gene Delivery Methods
Ex vivo Gene Therapy
Patient’s cells are removed and modified in a lab.
Modified cells are expanded and reintroduced.
Often used for blood or immune-related diseases.
In vivo Gene Therapy
Gene is delivered directly into the body.
Uses viral or non-viral vectors.
Common in treating muscular, lung, and liver disorders.
Gene Editing Technologies
CRISPR-Cas9
"Molecular scissors" that cut DNA at specific sites.
Easy to design and use.
TALENs (Transcription Activator-Like Effector Nucleases)
Uses engineered proteins to target specific DNA sequences.
More complex than CRISPR but precise.
ZFNs (Zinc Finger Nucleases)
Oldest gene editing technology.
Binds to specific DNA through zinc finger domains.
Delivery Vehicles (Vectors)
Viral Vectors
High efficiency in gene delivery.
Examples: Adenovirus, Lentivirus
Risk of immune response or insertional mutagenesis.
Non-viral Vectors
Safer, lower immune risk.
Examples: Liposomes, Naked DNA
Less efficient in gene delivery.
Choosing a Vector Depends On:
Target tissue
Type of disease
Required delivery method and safety profile
Stem Cells in Gene Therapy
What Are Stem Cells?
Undifferentiated cells that can become any cell type.
Crucial for tissue regeneration and repair.
Role in Gene Therapy:
Can be genetically modified to correct genetic defects.
Used in bone marrow transplants and experimental organ regeneration.
Potential Applications:
Repair damaged heart tissue after a heart attack.
Restore nerve function in spinal injuries.
Cure inherited blood disorders like thalassemia or sickle cell anemia.
Potential Benefits to Global Health
Treatment and Cure of Genetic disorders
Conditions such as cystic fibrosis, sickle cell anemia, muscular dystrophy, and certain types of inherited blindness can be targeted by inserting, altering, or repairing the faulty genes responsible.
Infectious diseases
Gene therapy can also be used to combat infectious diseases by modifying immune cells to better detect and destroy pathogens like HIV or hepatitis viruses.
It could transform the management of such diseases, especially in parts of the world where access to ongoing antiviral treatment is limited, ultimately helping to reduce transmission rates and improve public health outcomes.
Regenerative Medicine
Gene therapy in regenerative medicine offers significant potential for global health by addressing the root causes of genetic and chronic diseases.
By using genetically modified stem cells to repair or replace damaged tissues and organs, it enables more effective, long-lasting treatments.
This approach can reduce the global burden of incurable conditions, lessen dependence on organ transplants, and improve quality of life.
With continued advancement, gene therapy could become a cost-effective and accessible solution for populations worldwide, promoting health equity and transforming modern healthcare.
Cancer Therapy
Gene-modified immune cells, such as in CAR-T cell therapy, offer a targeted approach to cancer treatment by engineering immune cells to recognize and destroy cancer cells.
This reduces damage to healthy tissue and improves treatment effectiveness.
These therapies are especially promising for resistant or relapsed cancers and have the potential to transform global cancer care by providing personalized, less toxic, and more effective treatment options.
Detriments and Ethical Considerations
Health Risks
IMMUNE RESPONSE
The body may recognize the vectors (usually viruses) used in gene therapy as foreign and mount an immune response that can cause inflammation, flu-like symptoms, or even severe allergic reactions.
OFF TARGETS EFFECT
The new and unpredictable technology of gene regulation and mechanisms of embryonic development can lead to unknown consequences or even fatality.
GENETIC MOSAICISM
Condition where an individual has two or more genetically different sets of cells in their body, all originating from a single fertilized egg which can affect any tissue and may cause mild or patchy symptoms of genetic disorders.
UNINTENDED MUTATIONS
Accidental changes in the DNA that occur during the editing or gene insertion process that can develop cancer if mutations affect genes that control cell growth or loss of function in important genes.
TRANSMISSION TO GERMLINE CELL
Genetic changes made during treatment could affect a person’s sperm or egg cells.
UNCONTROLLED CELL GROWTH
Gene therapy can inadvertently stimulate uncontrolled cell growth, increasing the risk of tumors.
Accessibility and Equality
High Cost Treatment
Limited Geographic Availability (mostly located in high-income countries)
Lack of Diversity in Clinical Trials in term of racial, ethnic, and genetic backgrounds.
Potential Misuse leading to decrease public trust
Unequal Access and Awareness
Social Concerns
Look at how something affects society as a whole, including issues like inequality, culture, religion, public opinion, and community values.
Ethical Concerns
Focus on what is right or wrong, fair or unfair, and how actions affect individuals' rights, dignity, and well-being.
Ethical and Social Concerns
Germline Editing and “Designer Babies”
May prevent genetic diseases but can lead to non-medical trait selection that raises fear of “designer babies” with enhanced traits (e.g., intelligence, looks).
Could increase social inequality—only the wealthy may afford enhancements.
Risk of commodifying children as products rather than individuals.
Religious and Cultural Objections
Seen by some as interference with divine will or natural life.
Embryos may be viewed as having moral status—editing seen as unethical.
Some cultures consider altering inherited traits as taboo or disrespectful.
Fear of reinforcing cultural or racial biases (e.g., gender, skin tone).
Informed Consent Challenges
Future children cannot consent to changes affecting them.
Long-term effects are uncertain, making informed decision-making difficult.
Donors and parents may not fully understand risks and implications.
Vulnerable groups may face coercion or misinformation during consent.
Gender-Specific Considerations in Global Health
Why Gender Matters:
Global health interventions must consider gender differences to be effective and equitable.
Biological Differences:
Certain genetic diseases occur more frequently in one sex than the other.
Example: Hemophilia (more common in men), Autoimmune diseases (more common in women).
Hormonal variations influence how men and women respond to treatments.
Therapeutic Response Variability:
Hormones can influence the effectiveness of medications and therapies.
Example: Estrogen may affect stem cell behavior, impacting recovery and healing.
Clinical Implications:
Drug development and dosage recommendations must consider sex-based differences.
Tailored treatment approaches improve outcomes and minimize side effects.
Social and Cultural Barriers
Access to healthcare and advanced therapies is not equal across genders, particularly in low-resource settings.
In many regions, women face cultural and economic barriers that limit their ability to receive timely and effective medical treatment.
Furthermore, clinical research often displays gender bias, with a historical underrepresentation of women in trials. This can lead to differences in how medications and therapies perform across genders.
Reproductive Health
Germline Gene Therapy:
Alters reproductive cells (egg or sperm), affecting future generations.
Greater complexity when targeting female reproductive cells (eggs) due to limited number and developmental timing.
Ethical Concern:
Editing eggs vs. sperm raises different ethical debates.
Long-term effects on offspring and consent from future generations remain unresolved.